4 Mg Lenvima Capsules are prescribed for treatment of various kinds of thyroid cancers. They are formulated having lenvatinib as active drug which works by inhibiting VEGFR1, 2, & 3 enzymes. These capsules are also known to work by inhibiting fibroblast growth factor receptors and platelet derived growth factor receptors. 4 Mg Lenvima Capsules quickly get absorbed in gut and their high blood plasma concentration reaches after around four hours.
Metabolized by aldehyde oxidase and CYP3A4
Have bioavailability of around 85%
Protein binding ability range of 98 to 99%